Innovations in Immune-Mediated Skin Conditions Webinar Series

During this session, presenters will provide an overview of the disease burden of alopecia areata, discuss health care costs and utilization, highlight the patient-specific factors that must be considered when making treatment decisions for a diverse population, and explore the FDA-approved and pipeline pharmacologic treatment options for alopecia areata.

Learning Objectives 

At the completion of this knowledge-based activity, participants should be able to: 

1. Describe the disease burden of moderate-to-severe alopecia areata on clinical and patient-reported outcomes.
2. Differentiate new and emerging targeted therapies for alopecia areata based on mechanisms of action, efficacy and safety data, and indications.
3. Discuss approaches to managing alopecia areata among a diverse patient population.
4. Identify strategies to manage health care utilization and costs related to alopecia areata.

Target Audience 

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings. 

Faculty  

• Loren Krueger, MD, FAAD
  Assistant Professor, Dermatology
  Vice Chair, Diversity, Equity and Inclusion
  Emory University School of Medicine
• Steven Kheloussi, PharmD, MBA
  Manager, Clinical Pharmacy
  Highmark, Inc.

Moderators 

• Kellie Rademacher, PharmD
  Director Strategy
  Evoke Navience
• Lynn Deguzman, PharmD, BCGP
  Clinical Pharmacy Services Director, National Pharmacy
  Kaiser Permanente

Agenda  

5:30–5:35 pm — Welcome and Introductions 

Moderator

5:35–6:25 pm — Presentation: Innovations in Immune-Mediated Skin Conditions: Focus on Alopecia Areata 

• Loren Krueger, MD, FAAD
• Steven Kheloussi, PharmD, MBA

6:25-6:30 pm — Audience Q&A 

Moderator

Continuing Education Credit — Pharmacists 

The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias. 

Earning CPE Credit 

To earn continuing pharmacy education (CPE) credit for this program, you must attend the entire session and participate in the pre- and post-test questions.

• ACPE UAN #: 0233-0000-22-055-L01-P
• Credit:  1 Contact Hours Or 0.1 CEUs
• Activity Type: Knowledge-based 
• Activity Fee: There is no fee to participate in this activity. 

During this session, presenters will provide an overview of the disease burden of atopic dermatitis, discuss management strategies for controlling health care costs and ensuring appropriate utilization, highlight the patient-specific factors considered when making treatment decisions for a diverse population, and explore the rapidly expanding treatment options and emerging pipeline for atopic dermatitis.

Learning Objectives 

At the completion of this knowledge-based activity, participants should be able to: 

1. Describe the disease burden of moderate-to-severe atopic dermatitis on clinical and patient-reported outcomes.
2. Differentiate new and emerging targeted therapies for atopic dermatitis based on mechanisms of action, efficacy and safety data, and indications.
3. Discuss approaches to managing atopic dermatitis among a diverse patient population.
4. Identify strategies to manage health care utilization and costs related to atopic dermatitis.

Target Audience 

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings. 

Faculty  

• Junko Takeshita, MD, PhD, MSCE
  Assistant Professor of Dermatology and Epidemiology
  University of Pennsylvania Perelman School of Medicine
• Steven Kheloussi, PharmD, MBA
  Manager, Clinical Pharmacy
  Highmark Inc.

Moderators 

• Kellie Rademacher, PharmD
  Director Strategy
  Evoke Navience
• Lynn Deguzman, PharmD, BCGP
  Clinical Pharmacy Services Director, National Pharmacy
  Kaiser Permanente

Agenda  

3:00-3:05 pm — Welcome and Introductions 

Moderator

3:05-3:55 pm — Presentation: Innovations in Immune-Mediated Skin Conditions: Focus on Atopic Dermatitis

Junko Takeshita, MD, PhD, MSCE

Steven Kheloussi, PharmD, MBA

3:55-4:00 pm — Audience Q&A 

Moderator

Continuing Education Credit — Pharmacists 

The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias. 

Earning CPE Credit 

To earn continuing pharmacy education (CPE) credit for this program, you must attend the entire session and participate in the pre- and post-test questions.

• ACPE UAN #: 0233-0000-22-056-L01-P

• Credit: 1 Contact Hours Or 0.1 CEUs

• Activity Type: Knowledge-based 

• Activity Fee: There is no fee to participate in this activity. 

Steven S. Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy
Highmark Inc.

Steve Kheloussi is the manager of the Clinical Pharmacy Strategies (CPS) team at Highmark Inc. He is also an adjunct faculty member at Wilkes University where he teaches managed care courses in both the PharmD and the MBA programs. Steve specializes in formulary management and managed care education and has extensive experience in medication therapy management, quality and population health, utilization management, and specialty contracting and trend management. Steve currently serves on the AMCP Educational Affairs Committee and is the faculty advisor of the Wilkes University AMCP chapter. His passion for student success and engagement led him to being selected as the recipient of the 2022 AMCP Experiential Preceptor of the Year award.